Jun 1, 2026 07:47AM
May 22, 2026 02:00PM
May 22, 2026 01:42PM
May 22, 2026 09:54AM
May 21, 2026 05:55AM
May 21, 2026 05:51AM
May 20, 2026 04:19PM Gilead Sciences issues $3 billion in senior notes across four tranches
May 11, 2026 08:42AM
May 8, 2026 06:18AM
May 8, 2026 04:42AM
May 7, 2026 04:07PM
May 7, 2026 10:38AM
May 6, 2026 11:08AM
Apr 16, 2026 06:33AM RBC Capital Reiterates Sector Perform Rating on Gilead Sciences (GILD), flags Yeztugo risks
Apr 14, 2026 12:03PM
Apr 13, 2026 05:52AM
Apr 9, 2026 07:03AM
Apr 8, 2026 09:14AM
Apr 8, 2026 09:02AM
Apr 8, 2026 08:52AM
Apr 8, 2026 07:45AM Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald on Likely Positive Call
Apr 8, 2026 06:01AM
Apr 7, 2026 08:59AM
Apr 7, 2026 08:32AM
Apr 7, 2026 08:01AM
Apr 6, 2026 07:39AM
Mar 31, 2026 09:32AM
Mar 31, 2026 06:19AM Galapagos enters partnership with Gilead for autoimmune drug development
Mar 27, 2026 11:27AM
Mar 24, 2026 03:02PM
Mar 24, 2026 08:13AM
Mar 24, 2026 06:36AM
Mar 24, 2026 05:23AM
Mar 23, 2026 06:30PM
Mar 23, 2026 12:34PM Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines - FT
Mar 17, 2026 07:36AM
Mar 10, 2026 05:38AM
Mar 10, 2026 05:38AM
Mar 10, 2026 05:38AM
Mar 6, 2026 08:25AM
Feb 25, 2026 01:50PM
Feb 25, 2026 10:02AM UBS Reiterates Buy Rating on Gilead Sciences (GILD) Following ACLX Acquisition Announcement
Feb 24, 2026 09:38AM
Feb 24, 2026 08:23AM
Feb 23, 2026 12:32PM
Feb 23, 2026 09:31AM
Feb 23, 2026 08:09AM
Feb 20, 2026 06:02AM
Feb 18, 2026 10:27AM Gilead Sciences (GILD) PT Raised to $175 at UBS
Feb 12, 2026 05:40AM

396,938 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All